Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB - US7437131094 - Common Stock

49.81 USD
-0.96 (-1.89%)
Last: 8/29/2025, 8:04:00 PM
49.81 USD
0 (0%)
After Hours: 8/29/2025, 8:04:00 PM
Fundamental Rating

4

PRLB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. PRLB has a great financial health rating, but its profitability evaluates not so good. PRLB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
In the past year PRLB had a positive cash flow from operations.
Of the past 5 years PRLB 4 years were profitable.
PRLB had a positive operating cash flow in each of the past 5 years.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

PRLB's Return On Assets of 1.99% is on the low side compared to the rest of the industry. PRLB is outperformed by 60.94% of its industry peers.
PRLB has a Return On Equity of 2.23%. This is in the lower half of the industry: PRLB underperforms 65.63% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.11%, PRLB is doing worse than 67.97% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PRLB is significantly below the industry average of 9.99%.
Industry RankSector Rank
ROA 1.99%
ROE 2.23%
ROIC 2.11%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 2.91%, PRLB is doing worse than 60.16% of the companies in the same industry.
PRLB's Profit Margin has declined in the last couple of years.
The Operating Margin of PRLB (4.38%) is worse than 64.84% of its industry peers.
In the last couple of years the Operating Margin of PRLB has declined.
PRLB has a better Gross Margin (44.17%) than 81.25% of its industry peers.
PRLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.38%
PM (TTM) 2.91%
GM 44.17%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRLB is destroying value.
The number of shares outstanding for PRLB has been reduced compared to 1 year ago.
PRLB has less shares outstanding than it did 5 years ago.
PRLB has a better debt/assets ratio than last year.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

PRLB has an Altman-Z score of 10.55. This indicates that PRLB is financially healthy and has little risk of bankruptcy at the moment.
PRLB has a better Altman-Z score (10.55) than 93.75% of its industry peers.
The Debt to FCF ratio of PRLB is 0.01, which is an excellent value as it means it would take PRLB, only 0.01 years of fcf income to pay off all of its debts.
PRLB has a better Debt to FCF ratio (0.01) than 93.75% of its industry peers.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PRLB (0.00) is better than 88.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 10.55
ROIC/WACC0.2
WACC10.36%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

PRLB has a Current Ratio of 3.31. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
PRLB has a Current ratio of 3.31. This is in the better half of the industry: PRLB outperforms 79.69% of its industry peers.
PRLB has a Quick Ratio of 3.09. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.09, PRLB belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 3.09
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

PRLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.14%.
PRLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.19% yearly.
The Revenue has decreased by -0.12% in the past year.
PRLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-9.14%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%7.89%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.51%

3.2 Future

Based on estimates for the next years, PRLB will show a small growth in Earnings Per Share. The EPS will grow by 0.06% on average per year.
PRLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.72% yearly.
EPS Next Y-9.01%
EPS Next 2Y0.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.56%
Revenue Next 2Y4.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.33, the valuation of PRLB can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of PRLB indicates a slightly more expensive valuation: PRLB is more expensive than 63.28% of the companies listed in the same industry.
PRLB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.13.
With a Price/Forward Earnings ratio of 30.52, PRLB can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRLB indicates a slightly more expensive valuation: PRLB is more expensive than 67.97% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of PRLB to the average of the S&P500 Index (22.76), we can say PRLB is valued slightly more expensively.
Industry RankSector Rank
PE 31.33
Fwd PE 30.52
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

60.94% of the companies in the same industry are cheaper than PRLB, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PRLB is valued a bit cheaper than 72.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.04
EV/EBITDA 18.74
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (8/29/2025, 8:04:00 PM)

After market: 49.81 0 (0%)

49.81

-0.96 (-1.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners93.84%
Inst Owner Change-1.46%
Ins Owners1.05%
Ins Owner Change1.82%
Market Cap1.19B
Analysts76.36
Price Target51 (2.39%)
Short Float %2.71%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.34%
Min EPS beat(2)10.87%
Max EPS beat(2)17.81%
EPS beat(4)4
Avg EPS beat(4)22.12%
Min EPS beat(4)10.87%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)29.73%
EPS beat(12)11
Avg EPS beat(12)24.46%
EPS beat(16)14
Avg EPS beat(16)22.81%
Revenue beat(2)2
Avg Revenue beat(2)1.71%
Min Revenue beat(2)0.02%
Max Revenue beat(2)3.41%
Revenue beat(4)3
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-0.63%
Max Revenue beat(4)3.41%
Revenue beat(8)5
Avg Revenue beat(8)0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)8
Avg Revenue beat(16)0.22%
PT rev (1m)11.11%
PT rev (3m)11.11%
EPS NQ rev (1m)5.66%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)6.21%
EPS NY rev (3m)6.21%
Revenue NQ rev (1m)3.23%
Revenue NQ rev (3m)3.15%
Revenue NY rev (1m)2.04%
Revenue NY rev (3m)2.17%
Valuation
Industry RankSector Rank
PE 31.33
Fwd PE 30.52
P/S 2.34
P/FCF 18.04
P/OCF 16.74
P/B 1.79
P/tB 3.21
EV/EBITDA 18.74
EPS(TTM)1.59
EY3.19%
EPS(NY)1.63
Fwd EY3.28%
FCF(TTM)2.76
FCFY5.54%
OCF(TTM)2.97
OCFY5.97%
SpS21.31
BVpS27.85
TBVpS15.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.99%
ROE 2.23%
ROCE 3.27%
ROIC 2.11%
ROICexc 2.48%
ROICexgc 5.07%
OM 4.38%
PM (TTM) 2.91%
GM 44.17%
FCFM 12.96%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 14.62%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 123.98%
Profit Quality 444.91%
Current Ratio 3.31
Quick Ratio 3.09
Altman-Z 10.55
F-Score6
WACC10.36%
ROIC/WACC0.2
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.14%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%7.89%
EPS Next Y-9.01%
EPS Next 2Y0.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.51%
Revenue Next Year4.56%
Revenue Next 2Y4.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.61%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year58.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.71%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y12.72%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%